Abstract

PRESCRIBING PATTERNS AND ASSESSMENT OF SAFETY PROFILE OF DUAL ANTIPLATELET DRUGS IN CORONARY ARTERY DISEASE PATIENTS

*Rachuri Aparna, *Sana Goher, *Marni Dhruthi Chowdary, *Musku Srivani, *Dr. P. D. S. S. Prakash and *Dr. Maleha Butul

Abstract

Coronary artery disease (CAD), characterized by reduced blood flow to the heart due to atherosclerotic plaque buildup, affects approximately 1 in 3 healthy individuals according to current trends. Dual antiplatelet therapy (DAPT) has shown significant improvements in patient safety compared to monotherapy, particularly in minimizing hemorrhagic events. Consequently, DAPT has emerged as a major strategy for enhancing the safety profile in CAD patients.

Keywords: Coronarey artery disease, Dual anti platelet therapy, Ecospirin, Ticagrelor, Adverse drug reactions.